Primary prevention of dementia
Symptomatic treatments that work by enhancing neurotransmitter function have been available for several years, and are generally accepted as being modestly beneficial in about 50% of those for whom they are prescribed. Disease-modifying drugs that may prevent or retard neuronal deterioration are bei...
Príomhchruthaitheoir: | Wilcock, G |
---|---|
Formáid: | Book section |
Foilsithe / Cruthaithe: |
2004
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Methodological issues in primary prevention trials for neurodegenerative dementia.
de réir: Andrieu, S, et al.
Foilsithe / Cruthaithe: (2009) -
Dementia with Lewy bodies.
de réir: Wilcock, G
Foilsithe / Cruthaithe: (2003) -
The ageing brain and dementia.
de réir: Wilcock, G
Foilsithe / Cruthaithe: (1981) -
Memantine for the treatment of dementia.
de réir: Wilcock, G
Foilsithe / Cruthaithe: (2003) -
A review of dementia.
de réir: Wilcock, G
Foilsithe / Cruthaithe: (1982)